Trastuzumab and pertuzumab

Descriptions Trastuzumab injection is used to treat HER2-overexpressing new or metastatic breast cancer It can be

Intravenous trastuzumab is effective as a single-agent, and in combination with chemotherapy it significantly improves the median time to disease

trastuzumab trastuzumab beyond progression Trastuzumab is generally well tolerated and does not cause many of the toxicities or side effects seen with conventional

trastuzumab A study of more than 4000 patients, published in 2014, showed that adding trastuzumab to chemotherapy led to a 37% relative improvement in